Cipher Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.822; its P/E ratio is 8.25; Cipher Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 6.07M	$ 5.29M	$ 4.89M	$ 8.42M	$ 4.79M
Gross Profit	$ 4.99M	$ 4.23M	$ 3.91M	$ 7.49M	$ 3.93M
EBIT	$ 7.15M	$ 3.17M	$ 2.71M	$ 6.18M	$ 2.21M
EBITDA	$ 7.42M	$ 3.51M	$ 3.05M	-	$ 2.55M
Net Income Common Stockholders	$ 7.03M	$ 3.07M	$ 2.63M	$ 23.19M	$ 2.65M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 42.09M	$ 36.34M	$ 33.43M	$ 28.84M	$ 27.48M
Total Assets	$ 90.53M	$ 80.61M	$ 76.96M	$ 73.78M	$ 57.43M
Total Debt	$ 353.00K	$ 386.00K	$ 403.00K	$ 428.00K	$ 446.00K
Net Debt	$ -41.73M	$ -35.95M	$ -33.02M	$ -28.41M	$ -27.03M
Total Liabilities	$ 12.98M	$ 10.41M	$ 9.82M	$ 9.70M	$ 12.99M
Stockholders Equity	$ 77.55M	$ 70.20M	$ 67.14M	$ 64.08M	$ 44.45M
Cash Flow	-
Free Cash Flow	$ 5.97M	$ 2.95M	$ 4.67M	$ 1.47M	$ 3.77M
Operating Cash Flow	$ 5.97M	$ 2.95M	$ 4.67M	$ 1.47M	$ 3.85M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -27.00K	$ -242.00K	$ -34.00K	$ -189.00K	$ -292.00K

Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Income Statement >

Cipher Pharmaceuticals Debt to Assets

Balance Sheet >

Cipher Pharmaceuticals Cash Flow

Cash Flow >

Cipher Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing